Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ARNNY | BMNR |
|---|---|---|
| Price | $40.41 | $26.79 |
| Change today | ▲ 0.60% | ▲ 1.98% |
| Market cap | $16.19B | $16.16B |
| Return, 3 months | +6.5% | +81.0% |
| Return, year to date | +19.5% | -1.3% |
| Return, 1 year | +27.9% | -57.6% |
| P/E (TTM) | 13.5 | -6.0 |
| P/B | 1.4 | 1.4 |
| P/E percentile vs own 5y | – | 35th |
| Dividend yield | 5.11% | 0.04% |
| Revenue growth (YoY, latest qtr) | – | +2,167.8% |
| Net profit growth (YoY) | – | -13,318.1% |
| Gross margin | – | 84.4% |
| Operating margin | – | -15,823.0% |
| Net margin | – | -14,334.8% |
| Return on equity | – | -151.2% |
| Analyst target vs. price | – | +82.2% |
| Analyst buy share | – | 100% |
| RSI (14) | 42 | 57 |
| 30-day volatility | 23.8% | 80.4% |
| Max drawdown, 1 year | -11.9% | -78.9% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
